UBS Group AG - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2023$214
-66.9%
47
-61.8%
0.00%
Q1 2023$646
-97.2%
123
-97.4%
0.00%
Q4 2022$22,949
+14.7%
4,674
+50.6%
0.00%
Q3 2022$20,000
+566.7%
3,104
+508.6%
0.00%
Q2 2022$3,000
-75.0%
510
-70.8%
0.00%
Q1 2022$12,000
+50.0%
1,746
+41.4%
0.00%
Q4 2021$8,000
-11.1%
1,235
+7.0%
0.00%
Q3 2021$9,000
-52.6%
1,154
-58.5%
0.00%
Q2 2021$19,000
+850.0%
2,779
+533.0%
0.00%
Q1 2021$2,000
-75.0%
439
-71.3%
0.00%
Q4 2020$8,0001,527
+3293.3%
0.00%
Q3 2020$0
-100.0%
45
-96.7%
0.00%
Q2 2020$7,000
+133.3%
1,380
+191.1%
0.00%
Q1 2020$3,000
-87.0%
474
-81.3%
0.00%
Q4 2019$23,000
+35.3%
2,533
+32.6%
0.00%
Q3 2019$17,000
-51.4%
1,910
-44.4%
0.00%
Q2 2019$35,000
-66.0%
3,435
-37.5%
0.00%
Q3 2018$103,000
+2475.0%
5,499
+2556.5%
0.00%
Q2 2018$4,000
-81.0%
207
-78.5%
0.00%
Q1 2018$21,000
+600.0%
961
+861.0%
0.00%
Q2 2017$3,000
-92.9%
100
-95.2%
0.00%
Q1 2017$42,000
+16.7%
2,079
+40.2%
0.00%
Q4 2016$36,000
+50.0%
1,483
+23.0%
0.00%
Q3 2016$24,000
+700.0%
1,206
+503.0%
0.00%
Q2 2016$3,0000.0%2000.0%0.00%
Q1 2016$3,000
-88.5%
200
-92.3%
0.00%
Q4 2015$26,000
+36.8%
2,608
+38.9%
0.00%
Q3 2015$19,000
+533.3%
1,877
+838.5%
0.00%
Q2 2015$3,000
-87.0%
200
-85.5%
0.00%
Q1 2015$23,000
-50.0%
1,381
-54.7%
0.00%
Q4 2014$46,0003,0500.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders